Market News Archives

From Under the Radar to Over the Moon? Raymond James Puts a Strong‑Buy Spotlight on Eupraxia – $EPRX $IBB $SNY $XBI )

by John F. Heerdink, Jr. March 9, 2026 419Views 0Likes

Eupraxia Pharmaceuticals (NASDAQ: EPRX) just earned a fresh vote of confidence from Raymond James, which is doubling down on its bullish thesis and arguing that the small-cap biotech now offers one of the most attractive risk/reward setups heading into 2026. The Raymond…

Electric Air Taxis Near Liftoff: Inside the Archer–Vertical Patent Dogfight

by John F. Heerdink, Jr. March 9, 2026 399Views 0Likes

The electric air‑taxi race is entering its “show me” phase: certification clocks are ticking, lawsuits are flying, and investors are trying to decide whether this is the next aviation super‑cycle or just another speculative layover. Air Taxis Near the Runway, Not Quite…

March 6, 2026 – Jobs Miss, Oil & Energy Stocks Pops: The Fed’s Soft‑Landing Story Fails the Turbulence Test -( $CVX $DV $FIGS $GOVX $INTG $NOK $NVDA $SHEL $SOAR $XOM Rise!)

by John F. Heerdink, Jr. March 6, 2026 2010Views 0Likes

US stocks ended a volatile week lower as surging oil prices and a weak jobs report revived inflation and growth fears, pressuring risk assets while lifting energy shares. Index performance Major US benchmarks fell on Friday and finished the week in the…

From “Soft Landing” to “Soft Thud”: What February Jobs Say Before the Fed Meets -( $DIA $QQQ $SPY $VIX )

by John F. Heerdink, Jr. March 6, 2026 496Views 0Likes

The latest jobs report delivered a jolt to Wall Street’s morning coffee, but not quite the recession-grade earthquake some feared. Jobs Growth Slams Into Reverse The US economy unexpectedly shed 92,000 jobs in February, abruptly ending the early‑year hiring momentum. Economists had…

Servier’s $2.5 Billion Bet on Rare Oncology: A Strategic Day One Biopharmaceuticals Play With a Pediatric Pulse -( $DAWN $XBI $IBB )

by John F. Heerdink, Jr. March 6, 2026 1161Views 0Likes

French pharmaceutical group Servier has quietly become one of the most methodical players in oncology—and its latest move underscores that reputation. The company announced a definitive agreement to acquire Day One Biopharmaceuticals (Nasdaq: DAWN) for $21.50 per share in cash, valuing the…

Formula 1 Hits Top Gear: How This Racing Empire Is Quietly Lapping Wall Street -( $AAPL $AMZN $CMCSA $FWONA $FWONK $LMOF.F $NFLX )

by John F. Heerdink, Jr. March 5, 2026 472Views 0Likes

Formula 1 is roaring into the new season like a blue-chip stock breaking out of a long consolidation: higher revenues, richer media deals, and a global fan base that seems in no mood to lift its foot off the throttle. F1 Becomes…

March 5, 2026 – Dow Takes a Spill While Oil Climbs the Hill: Markets Brace for Impact -( $FIGS $GOVX $INTG $MODD $NVDA $OPEN Rise!)

by John F. Heerdink, Jr. March 5, 2026 1865Views 0Likes

US stocks sank Thursday as another spike in oil prices and intensifying Iran war fears reignited selling across equities and sent investors back into defensive mode. Index performance The Dow Jones Industrial Average dropped more than 784 points, or roughly 1.61% leading…

FDA’s New Bonus Plan: Can Cash Tips Speed Up Drug Reviews Without Cutting Corners? -( $IBB $XBI )

by John F. Heerdink, Jr. March 5, 2026 311Views 0Likes

The U.S. Food and Drug Administration (FDA) is reportedly rolling out a new cash‑bonus program to reward drug reviewers who deliver high‑quality decisions ahead of schedule, a move pitched as both a modernization of government HR and a lifeline for an agency…

Oracle Cuts Thousands of Jobs to Build AI Data Centers: Firing on All Cloud Cylinders -( $ORCL $NVDA $SPY )

by John F. Heerdink, Jr. March 5, 2026 453Views 0Likes

Oracle’s (ORCL) latest round of layoffs is less a retreat than a high‑stakes reshuffling for the age of artificial intelligence, as the software giant trades payroll for power plants in a bid to secure its place in the cloud big leagues. A…

When AI Chips Order Room Service: Broadcom, Nvidia and Nokia Rewire the Data‑Center Hotel -( $AVGO $META $NOK $NVDA )

by John F. Heerdink, Jr. March 5, 2026 694Views 0Likes

Broadcom’s (AVGO) chief executive is sounding less like a cautious chipmaker and more like the maître d’ of a very exclusive AI banquet, calmly assuring investors that the kitchen can handle the rush. In this rapidly evolving feast, Nvidia (NVDA) is serving…

Market News

Your Guide To Staying Informed In The Markets